PFS | OS | ||||||
---|---|---|---|---|---|---|---|
HR | CI 95 % | p value | HR | CI 95 % | p value | ||
miR-34a expressionc | high | 0.549 | [0.31–0.969] | 0.039a | 0.509 | [0.293–0.883] | 0.016a |
low | 1 | ||||||
FIGO stage | late | 1.646 | [0.7–3.871] | 0.253 | 2.058 | [0.895–4.727] | 0.089 |
early | 1 | ||||||
Age | >62.3 | 1.69 | [1.017–2.813] | 0.043a | 2.565 | [1.571–4.189] | <0.0001b |
<62.3 | 1 | ||||||
Residual disease | RD > 0 | 1.97 | [1.057–3.674] | 0.033a | 2.565 | [1.571–4.189] | 0.001b |
RD = 0 | 1 | ||||||
Hystology | d | 0.998 | [0.773–1.288] | 0.987 | 1.132 | [0.886–1.446] | 0.321 |
Serous cancers | |||||||
PFS | OS | ||||||
HR | CI 95 % | p value | HR | CI 95 % | p value | ||
miR-34a expressionc | high | 0.509 | [0.227–1.143] | 0.102 | 0.389 | [0.173–0.876] | 0.022a |
low | 1 | ||||||
FIGO stage | late | 2.866 | [0.77–10.662] | 0.043 | 2.858 | [0.748–10.915] | 0.125 |
early | 1 | ||||||
Age | >62.3 | 2.304 | [1.082–4.905] | 0.032 | 2.925 | [1.386–6.174] | 0.005 |
<62.3 | 1 | ||||||
Residual disease | RD > 0 | 1.194 | [0.456–3.128] | 0.718 | 1.080 | [0.397–2.938] | 0.879 |
RD = 0 | 1 |